Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KeyCorp (KEY) vs 22nd Century Group Inc (XXII) Price & Performance

KeyCorpTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

KeyCorp vs 22nd Century Group Inc — how do they compare? KeyCorp trades at $23.55 (market cap $25.17B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: KeyCorp is far larger — about 16892.6× 22nd Century Group Inc's market cap, and KeyCorp pays a 3.52% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.

KEYXXII
Market Cap
$25.17B$1.49M
Sector
FinancialsTechnology
52-Week High
$23.99$1.07K
52-Week Low
$16.78$3.90
Dividend Yield
3.52%
Enterprise Value
-$6.74M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KeyCorp

KeyCorp (KEY) trades at $22.95, down 2.55% today, but maintains strong fundamentals with a P/E of 14.31 and consistent earnings beats. The company reported Q2 2026 EPS of $0.44, beating estimates by 6.4%, driven by 7% revenue growth and expanding net interest margins. Technical indicators show a bullish moving average signal while oscillators remain neutral, with support at $23 and resistance at $24.

Outlook remains positive with analyst consensus price target of $31.06 (35% upside) and 61% buy ratings. Key risks include interest rate sensitivity and competitive banking pressures, but strong capital position and strategic acquisitions support growth trajectory through 2027.

22nd Century Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KeyCorp

With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

Read more on KEY

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII